Naoki Nishimoto

Validation of a Novel Cutoff Point for the Fibrosis-4 Index Modified by Age in Patients with Fatty Liver Diseases

S. Fukumoto, A. Tamori, Tatsuo Kimura, 2021 .

HOMA‐IR: An independent predictor of advanced liver fibrosis in nondiabetic non‐alcoholic fatty liver disease

K. Chayama, Hirokazu Takahashi, Y. Eguchi, 2019, Journal of gastroenterology and hepatology.

The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional study

N. Kawada, H. Fujii, Seiko Yamaguchi, 2016, BMC Public Health.

The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

S. Fukumoto, A. Tamori, Tatsuo Kimura, 2021, Scientific Reports.

The Alcohol Use Disorders. Identification Test (AUDIT) score is useful for predicting alcohol consumption.

N. Kawada, H. Fujii, Seiko Yamaguchi, 2016, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.

Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis

S. Fukumoto, A. Tamori, A. Hagihara, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study

H. Yoshiji, N. Enomoto, T. Kawaguchi, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.